India is expected to become world’s most populated country by 2050, with the numbers reaching 1.7 billion. This will need leapfrogging in healthcare delivery including the transformation of the public healthcare system. The future of healthcare will see a delivery model which is more personalized and focused on preventive and predictive healthcare contrary to the existing reactive and curative care.
With personalized, predictive, preventative, and participatory drugs paving the way to improve care, a distinct trend is observed in the transformational breakthrough at an affordable and manageable cost. The Indian pharmaceuticals industry will be driven by a breakthrough in technologies used to discover new drugs and the processes used to clinically evaluate them in the near future. Human genome engineering platform will pave the way for the modification of disease-causing genes in humans and vaccines for major infectious killers in India such as malaria and AIDS will be widely available and distributed. The nation will also witness advancement in proactive medicines that rely on continuous stratification of ‘at-risk’ individuals and low-cost bio-electronic devices that could be implanted inside the body.
Doctors will be able to interact with the patients universally, diagnose problems and offer personalized services, thanks to the availability of medical data from wearable and other sensors. India is on its way to become the centre of frugal innovation to develop affordable solutions and products such as wearable organs through 3D printing. Self-diagnostics, self-monitoring, and self-medication will take over for a majority of the urban population. As for the rural counterpart, they won’t be left behind as well and will be well connected digitally and point of service available within home premises for primary and secondary healthcare services.